Φορτώνει...
The Canadian Methotrexate and Etanercept Outcome Study: a randomised trial of discontinuing versus continuing methotrexate after 6 months of etanercept and methotrexate therapy in rheumatoid arthritis
OBJECTIVE: To determine if withdrawing methotrexate (MTX) after 6 months of combination etanercept (ETN)+MTX, in MTX-inadequate responders with active rheumatoid arthritis (RA), is non-inferior to continuing ETN+MTX. METHODS: Tumour necrosis factor-inhibitor naïve RA patients with disease activity s...
Αποθηκεύτηκε σε:
| Μορφή: | Άρθρο |
|---|---|
| Γλώσσα: | en |
| Έκδοση: |
BMJ Publishing Group
2014
|
| Θέματα: | |
| Διαθέσιμο Online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4251190/ https://ncbi.nlm.nih.gov/pubmed/23979914 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/annrheumdis-2013-203684 |
| Ετικέτες: |
Προσθήκη ετικέτας
Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!
|